News
Academy
Publications
All PublicationsE-Books
Media
Editorial PodcastsEditorial VideosPeer ExchangePractice AcademySponsored PodcastsSponsored Videos
More
Conferences
Conference CoverageConference Listing
Columns
All ColumnsA Closing ThoughtClinical Trial InsightsView from BrusselsView from Washington
Resources
AdvertiseBlogsEventsFront & CenterPartner PerspectivesWhite Papers
Webcasts

Subscribe

  • News
  • Academy
  • Publications
  • Media
  • Conferences
  • Columns
  • Resources
  • Webcasts
  • Subscribe
  • Clinical Operations & Strategy
    • Decentralized Clinical Trials
    • Trial Design
    • Investigative Sites
    • CRO/Sponsor
    • Risk-Based Monitoring
    • Protocol Design
    • Clinical Trial Supply Chain
    • Study Start-Up
    • Early Phase Development
  • DEI
    • Industry Initiatives
    • Diversity Action Plans
    • Recruitment
  • Data Management
    • Analytics
    • Electronic Data Capture
    • Real World Evidence
    • Metrics & Benchmarks
  • Patient Participation
    • Integrated Research
    • CRAACO
    • Enrollment
  • Regulatory
    • Institutional Review Board & Ethics Committee
    • FDA
    • EMA
  • Technology
    • Artificial Intelligence/Machine Learning
    • eClinical
    • mHealth
Spotlight -
CNS Drug Development Resources|
Conference Coverage|
Peer Exchange|
DE&I|
Editorial Videos
Advertisement
|Articles|October 1, 2014

ACT 2015 Editorial Calendar

ACT 2015 Editorial Calendar

Advertisement
External Link - article-859064.pdf

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!
Advertisement

Related Content

Advertisement

Imfinzi Regimen Demonstrates 22% Survival Benefit in Early Gastric and GEJ Cancer

ByNancy Ghattas,Andy Studna, Senior Editor
October 29th 2025

ACT Brief: AI Partnerships, Data-Driven Site Activation, and FDA Approval for Omvoh’s Single-Injection Regimen

ByAndy Studna, Senior Editor
October 29th 2025

Using Global Patient Data to Design Smarter, More Inclusive Clinical Trials

ByGen Li, PhD, MBA,Andy Studna, Senior Editor
October 29th 2025
© Kaikoro - © Kaikoro - stock.adobe.com

Thermo Fisher, Lundbeck Announce New OpenAI Partnerships Advancing AI in Drug Development

ByAndy Studna, Senior Editor
October 28th 2025

ACT Brief: AI Expands Global Site Leadership as Ozempic Shows Potential to Reverse Biological Age

ByAndy Studna, Senior Editor
October 28th 2025
Advertisement
Advertisement

Trending on Applied Clinical Trials Online

1

Thermo Fisher, Lundbeck Announce New OpenAI Partnerships Advancing AI in Drug Development

2

Using Global Patient Data to Design Smarter, More Inclusive Clinical Trials

3

ACT Brief: AI Expands Global Site Leadership as Ozempic Shows Potential to Reverse Biological Age

4

ACT Brief: AI Partnerships, Data-Driven Site Activation, and FDA Approval for Omvoh’s Single-Injection Regimen

5

Building Broader Investigator Networks to Advance Global Breast Cancer Research

  • About
  • Advertise
  • Contact Us
  • Editorial Contacts
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

  • Applied Clinical Trials
  • BioPharm International
  • Cannabis Science and Technology
  • Chromatography Online
  • Nutritional Outlook
  • Pharmaceutical Commerce
  • Pharmaceutical Executive
  • Pharm Tech
  • Spectroscopy Online
  • Turbo Machinery Magazine
IS1
Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us